GANODERMA LUCIDUM SPORES POLYSACCHARIDES

Manufacturer
Bestway Biomedical Technology (Shanghai) Co., Ltd.
Effective date
2023-06-18
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 23:55:17

Label at a glance#

ProductGANODERMA LUCIDUM SPORES POLYSACCHARIDES
Active ingredientAMINO ACIDS, BARLEY MALT
Label structure12 sections

Indications and uses

Uses Regulating immunity

Storage and handling

Other information store at 20-25°C(68-77°F) protect from excessive moisture

Label contents#

Full prescribing information#

Active lngredient(in each tablet):

OTC - ACTIVE INGREDIENT SECTION

Active lngredient(in each tablet): Amino acids 2%, BARLEY MALT 1%

Purpose

OTC - PURPOSE SECTION


Purpose: Promote cardiovascular and cerebrovascular health, Reaulate the immune system

Uses

INDICATIONS & USAGE SECTION


Uses
Regulating immunity

Warnings

WARNINGS SECTION


Warnings
For internal use only

Do not use

OTC - DO NOT USE SECTION


Do not use
lf you are allergic to any ingredients

When Using Section

OTC - WHEN USING SECTION


When Using Section
When using this product, do not take other medications at the same time.
lf taking antibiotics at the same time, please interva at least 2 hours or follow medical advice.
lf discomfort occurs after consumption, please stop usingand consult a doctor.

Stop Use Section

OTC - STOP USE SECTION


Stop Use Section
No side effects

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


Keep out of reach of children
Children, pregnant women, and nursing mothers should not consume it

Instructions:

DOSAGE & ADMINISTRATION SECTION


Instructions:
Once a day, 1 capsule each time, taken with warm water
Seal and place in a cool and dry place
This product cannot replace medication for treatment

Other information

STORAGE AND HANDLING SECTION


Other information
store at 20-25°C(68-77°F)
protect from excessive moisture

lnactive ingredient.

INACTIVE INGREDIENT SECTION


lnactive ingredient.
GANODERMA LUCIDUM SPORES POLYSACCHARIDES

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


83532-001-01
30 CAPSULE in 1BOX

83532-001-0183532-001-01

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
AMINO ACIDS Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
BARLEY MALT Pharmacologic Class Indexing2Indexing - Pharmacologic Class20181113

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83532-001-01GANODERMA LUCIDUM SPORES POLYSACCHARIDES30 in 1 BOXCAPSULE303

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83532-001GANODERMA LUCIDUM SPORES POLYSACCHARIDES CAPSULE [BESTWAY BIOMEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.]31 package rows20230619_fe4b3742-17dc-3de5-e053-6294a90aa2e7.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83532-00183532-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
REISHITKD8LH0X2ZIACT
AMINO ACIDS0O72R8RF8AACTIB
BARLEY MALTR3NBG8914UACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fe72826b-6c85-7a43-e053-6294a90a9d03fe4b3742-17dc-3de5-e053-6294a90aa2e72023-06-18WarningsExact identifier
spl id: fe72826b-6c85-7a43-e053-6294a90a9d03
spl set id: fe4b3742-17dc-3de5-e053-6294a90aa2e7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.